Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression

Behavioural Pharmacology

Volumn 15, Issue 8, 2004, Pages 523-534

  Tatarczynska E ^a   Klodzinska A ^a   Stachowicz, K ^a   Chojnacka Wojcik E ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5 HT1B receptors; Conflict drinking test; CP 94253; Forced swimming test; Four plate test; GR 127935; Mouse; Plus maze test; Rat; SB 216641

Indexed keywords

5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; ANTIDEPRESSANT AGENT; DIAZEPAM; IMIPRAMINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SB 216641; SEROTONIN 1B AGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D ANTAGONIST; SEROTONIN 1D RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR CONTROL; CONTROLLED STUDY; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SELECTIVITY; ELECTRIC SHOCK; EXPERIMENTAL TEST; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; RAT; THIRST; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; BEHAVIOR, ANIMAL; BENZAMIDES; CONFLICT (PSYCHOLOGY); DEPRESSIVE DISORDER; DIAZEPAM; ELECTROSHOCK; EXPLORATORY BEHAVIOR; IMIPRAMINE; MALE; MICE; MOTOR ACTIVITY; OXADIAZOLES; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; REACTION TIME; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SWIMMING;

EID: 11344259757     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200412000-00001     Document Type: Article

References (70)

1. 1D receptors in the regulation of serotonin cell firing and release in the rat brain. J Neurochem 79:172-182.
2. Aron C, Simon P, Larousse C, Boissier JR (1971). Evaluation of a rapid technique for detecting minor tranquilizers. Neuropharmacology 10:459-469.
3. Barnes NM, Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
4. Bell R, Donaldson C, Gracey D (1995). Differential effects of CGS 12066B and CP-94,253 on murine social and agonistic behaviour. Pharmacol Biochem Behav 52:7-16.
5. Belzung C, Le Pape G (1994). Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol Behav 56:623-628.
6. Borsini F (1995). Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 19:377-395.
7. Borsini F, Meli A (1988). Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94:147-160.
8. Borsini F, Meli A (1990). The forced swimming test: its contribution to the understanding of the mechanisms of action of antidepressants. Adv Biosci 77:63-76.
9. 1B/D receptors. In: Baumgarten HG, Göthert M (editors): Serotoninergic Neurons and 5-HT Receptors in the CNS. Berlin: Springer-Verlag; pp. 269-291.
10. 1B binding sites in rat brain. Naunyn Schmiedebergs Arch Pharmacol 347:569-582.
11. 1B knockout mice. Behav Neurosci 113:587-601.
12. Cervo L, Rozio M, EkalleSoppo CB, Carnovali F, Santangelo E, Samanin R (2002). Stimulation of serotonin (1B) receptors induces conditioned place aversion and facilitates cocaine place conditioning in rats. Psychopharmacology (Berl) 163:142-150.
13. 1B and benzodiazepine receptor ligands in the light/dark box anxiety model in mice. Soc Neurosci 24:601.
14. 1B/D receptor antagonists. Neurosci Lett 188:41-44.
15. Dawson GR, Tricklebank MD (1995). Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16:33-36.
16. 1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice. Eur J Pharmacol 476:71-77.
17. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology (Berl) 121:1-26.
18. 1A receptor knock-out mice, show reduced startle reactivity and footshock-induced sensitization, as measured with the acoustic startle response. Behav Brain Res 118:169-178.
19. 1B binding sites. Naunyn Schmiedebergs Arch Pharmacol 332:1-7.
20. 1A compounds by GABA-benzodiazepine agents in rats. Pharmacol Biochem Behav 60:27-32.
21. File SE (1992). Behavioural detection of anxiolytic action. In: Elliot JM, Heal DJ, Marsden CA (editors): Experimental Approaches to Anxiety and Depression. Chichester: Wiley; pp. 25-44.
22. 1B receptor agonist CP-94,253. Psychopharmacology (Berl) 146:391-399.
23. A receptors. Psychopharmacology (Berl) 149:277-285.
24. Gobert A, Rivet JM, Audinot V, Newman-Tancredi A, Cistarelli L, Millan MJ (1998). Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience 84:413-429.
25. 1B receptors causes hypothermia in the guinea pig. Eur J Pharmacol 331:169-174.
26. 1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: a microdialysis study. Neurosci Lett 225:57-60.
27. Handley SL (1995). 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 66:103-148.
28. Hoyer D, Middlemiss DN (1989). Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol Sci 10:130-132.
29. 1B antagonist. J Pharmacol Exp Ther 304:1072-1084.
30. Iyer RN, Bradberry CW (1996). Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J Pharmacol Exp Ther 277:40-47.
31. Janssen PAJ, Jagenau AHM, Schellekens KHC (1960). Chemistry and pharmacology of compound related to 4-(4-hydroxy-4-phenylpiperidino)- butyrophenone. IV. Influence of haloperidol (R-1625) and chloropromazine on the behaviour of rats in a unfamiliar open field situation. Psychopharmacologia (Berlin) 1:389-392.
32. 1B receptor agonist, CP-94,253. Drug Dev Res 26:241-250.
33. 1B agonist CP-94,253. Psychopharmacology (Berl) 164:49-60.
34. 1B receptor stimulation in the rat elevated plus-maze. Pharmacol Biochem Behav 71:581-587.
35. López-Rubalcava C, Saldívar A, Fernández-Guasti A (1992). Ineraction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics. Pharmacol Biochem Behav 43:433-440.
36. 1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J Neurosci 19:6157-6168.
37. 1D agonist: effects in drug discrimination and punishment procedures in the pigeon. Psychopharmacology (Berl) 128:313-319.
38. 1B receptor mutant mice. J Pharmacol Exp Ther 298:1101-1107.
39. McNamara MG, Kelly JP, Leonard BE (1995). Some behavioural effects of methiothepin in the olfactory bulbectomised rat model of depression. Med Sci Res 23:583-585.
40. Millan MJ (2003). The neurobiology and control of anxious states. Prog Neurobiol 70:83-244.
41. 1B receptors to G-protein coupling and function in corticolimbic structures in vivo. Neuropsychopharmacology 21:61-67.
42. Millan MJ, Lejeune F, Gobert A (2000). Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J Psychopharmacol 14:114-138.
43. 1B/D receptors in psychiatric disorders and their potential as a target for therapy. Eur J Pharmacol 404:1-12.
44. 1A receptor sensitivity in rat hypothalamus and hippocampus, respectively. Neuropharmacology 39:2309-2317.
45. O'Neill MF, Fernández AG, Palacios JM (1996). GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test. Pharmacol Biochem Behav 53:535-539.
46. Pellow S, File S (1986). Anxiolytic and anxiogenic effects of drug effects on exploratory activity in an elevated plus-maze: novel test of anxiety in rats. Pharmacol Biochem Behav 24:525-529.
47. Pollard GT, Howard JCL (1989). Effects of drugs on punished behaviour: preclinical test for anxiolytics. Pharmacol Ther 45:403-424.
48. Porsolt RD, Bertin A, Jalfre M (1977). Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn 229:327-336.
49. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979). Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201-210.
50. 1D receptors. Naunyn Schmiedebergs Arch Pharmacol 356:312-320.
51. Przegaliński E, Tatarczyńska E, Chojnacka-Wójcik E (1989). Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine. J Psychopharmacol 3:180-185.
52. 1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig. Neuropharmacology 36:549-557.
53. 1B/D receptor antagonists in dorsal and median raphe innervated brain regions. Eur J Pharmacol 346:175-180.
54. Roberts C, Price GW, Middlemiss DN (2001). Ligands for the investigation of 5-HT autoreceptor function. Brain Res Bull 56:463-469.
55. Rodgers RJ (1997). Animal models of 'anxiety': where next? Behav Pharmacol 8:477-496.
56. Rollema H, Clarke T, Sprouse JS, Schultz DW (1996). Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo. J Neurochem 67:2204-2207.
57. 1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors. Naunyn Schmiedebergs Arch Pharmacol 356:321-327.
58. Schreiber R, Melon C, De Vry J (1998). The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology (Berl) 135:383-391.
59. 1D receptor antagonist GR 127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis. Neuropharmacology 34:377-382.
60. 1D receptor antagonist. Behav Brain Res 73:157-161.
61. 1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus. Neuropharmacology 33:393-402.
62. 1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 359:110-116.
63. 1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats. Pol J Pharmacol 54:615-623.
64. Treit D (1985). Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9:203-222.
65. 1B receptors: in vivo microdialysis studies. J Neurochem 69:2019-2025.
66. Vogel JR, Beer B, Clody DE (1971). A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia (Berlin) 21:1-7.
67. 1A receptor antagonists. Eur J Pharmacol 471:27-34.
68. 1A-receptor antagonist with anxiolytic-like activity, in mice and rats. J Pharm Pharmacol 55:533-543.
69. Yan QS, Yan SE (2001). Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur J Pharmacol 418:55-64.
70. 1B receptors. Neuropsychopharmacology 21:52-60.